-
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Addre...资讯2026-02-12
最热
